Other Stories

Moderna vaccine produces antibodies in all patients tested in initial safety trial Updated: 2020-07-15 13:27:11 KST

Another sign of a potential working vaccine from the U.S. company Moderna.
It says its vaccine produced antibodies to the coronavirus in all the patients it tested in an initial safety trial 45 of them in total.
Following the news, Moderna's stock rose on Tuesday by more than 16 percent.
Late stage trials of the vaccine will start on July 27th with 30-thousand participants.
They'll get a dose of 100 micrograms on the first day and another 29 days later.
Some patients will get a placebo.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.